MediumEndocrinologyInsulin initiation in type 2 diabetesau-amcau-racgp
A 58-year-old woman with long-standing type 2 diabetes managed with metformin and a sulfonylurea has an HbA1c of 9.8% (84 mmol/mol) and fasting glucose around 14 mmol/L despite adherence. She has no significant comorbidities and BMI is 32 kg/m². According to Australian guidance, what is the most appropriate next step in glucose-lowering therapy?